Access the full text.
Sign up today, get DeepDyve free for 14 days.
K. Beer, C. Boyd, Rina Patel, B. Bowen, S. James, M. Brin (2011)
Rapid onset of response and patient-reported outcomes after onabotulinumtoxinA treatment of moderate-to-severe glabellar lines.Journal of drugs in dermatology : JDD, 10 1
(2006)
Botulinum neurotoxins and injectable fillers: minimally invasive management of the aging upper faceFacial Plast Surg Clin North Am, 14
C. Maas (2006)
Botulinum neurotoxins and injectable fillers: minimally invasive management of the aging upper face.Otolaryngologic clinics of North America, 40 2
A. Carruthers, N. Sadick, F. Brandt, A. Almeida, S. Fagien, G. Goodman, H. Raspaldo, Kevin Smith, Sarah Darmody, Conor Gallagher, James Street, L. Romagnano (2015)
Evolution of Facial Aesthetic Treatment Over Five or More Years: A Retrospective Cross-sectional Analysis of Continuous OnabotulinumtoxinA TreatmentDermatologic Surgery, 41
Carruthers (2015)
693Dermatol Surg, 41
Derek Jones, Diane Murphy (2013)
Volumizing Hyaluronic Acid Filler for Midface Volume Deficit: 2‐Year Results from a Pivotal Single‐Blind Randomized Controlled StudyDermatologic Surgery, 39
A. Carruthers, S. Bruce, S. Cox, M. Kane, Elisabeth Lee, Conor Gallagher (2016)
OnabotulinumtoxinA for Treatment of Moderate to Severe Crow's Feet Lines: A Review.Aesthetic surgery journal, 36 5
Kiersten Coleman, J. Carruthers (2006)
Combination therapy with BOTOX™ and fillers: the new rejuvnation paradigmDermatologic Therapy, 19
V. Narurkar, A. Shamban, Peter Sissins, Anthony Stonehouse, Conor Gallagher (2015)
Facial Treatment Preferences in Aesthetically Aware WomenDermatologic Surgery, 41
L. Baumann, A. Shamban, Mary Lupo, G. Monheit, Jane Thomas, Diane Murphy, P. Walker (2007)
Comparison of Smooth‐Gel Hyaluronic Acid Dermal Fillers with Cross‐linked Bovine Collagen: A Multicenter, Double‐Masked, Randomized, Within‐Subject StudyDermatologic Surgery, 33
T. Pavicic, J. Few, Jürgen Huber-Vorländer (2013)
A novel, multistep, combination facial rejuvenation procedure for treatment of the whole face with incobotulinumtoxinA, and two dermal fillers- calcium hydroxylapatite and a monophasic, polydensified hyaluronic acid filler.Journal of drugs in dermatology : JDD, 12 9
Brandt (2011)
982J Drugs Dermatol, 10
Yu Guo, Yongzhou Lu, Tianyi Liu, Yiqun Zhou, Ping Yang, Jingjing Zhu, Liang Chen, Qingjian Yang (2015)
Efficacy and Safety of Botulinum Toxin Type A in the Treatment of Glabellar Lines: A Meta-Analysis of Randomized, Placebo-Controlled, Double-Blind TrialsPlastic and Reconstructive Surgery, 136
J Carruthers, A Carruthers (2003)
A prospective, randomized, parallel group study analyzing the effect of BTX-A (Botox) and nonanimal sourced hyaluronic acid (NASHA, Restylane) in combination compared with NASHA (Restylane) alone in severe glabellar rhytides in adult female subjects: treatment of severe glabellar rhytides with a hyaluronic acid derivative compared with the derivative and BTX-ADermatol Surg, 29
S. Dayan, W. Coleman, J. Dover, K. Boulle, James Street, L. Romagnano, S. Daniels, J. Kowalski, X. Lei, Elisabeth Lee (2015)
Effects of OnabotulinumtoxinA Treatment for Crow's Feet Lines on Patient-Reported OutcomesDermatologic Surgery, 41
J. Carruthers, R. Glogau, A. Blitzer (2008)
Advances in Facial Rejuvenation: Botulinum Toxin Type A, Hyaluronic Acid Dermal Fillers, and Combination Therapies–-Consensus RecommendationsPlastic and Reconstructive Surgery, 121
Pavicic (2013)
978J Drugs Dermatol, 12
Narurkar (2015)
S153Dermatol Surg, 41
A. Carruthers, J. Carruthers, G. Monheit, Paula Davis, Greg Tardie (2010)
Multicenter, Randomized, Parallel‐Group Study of the Safety and Effectiveness of OnabotulinumtoxinA and Hyaluronic Acid Dermal Fillers (24‐mg/mL Smooth, Cohesive Gel) Alone and in Combination for Lower Facial RejuvenationDermatologic Surgery, 36
V. Narurkar, Joel Cohen, S. Dayan, M. Kaminer, Alexander Rivkin, A. Shamban, J. Sykes, C. Teller, S. Weinkle, W. Werschler, Adrienne Drinkwater, Michael Pucci, Conor Gallagher (2016)
A Comprehensive Approach to Multimodal Facial Aesthetic Treatment: Injection Techniques and Treatment Characteristics From the HARMONY StudyDermatologic Surgery, 42
Carruthers (1996)
788J Am Acad Dermatol, 34
CS Maas (2006)
Botulinum neurotoxins and injectable fillers: minimally invasive management of the aging upper faceAesthetic Plast Surg, 14
M. Maio (2004)
The Minimal Approach: An Innovation in Facial Cosmetic ProceduresAesthetic Plastic Surgery, 28
Coleman (2006)
177Dermatol Ther, 19
Y Guo, Y Lu, T Liu (2015)
Efficacy and safety of botulinum toxin type A in the treatment of glabellar lines: a meta-analysis of randomized, placebo-controlled, double-blind trialsFacial Plast Surg Clin North Am, 136
Weinkle (2009)
205J Cosmet Dermatol, 8
Carruthers (2010)
2121Dermatol Surg, 36
Carruthers (2008)
5SPlast Reconstr Surg, 121
A Shamban (2015)
Customized approach to facial enhancementJ Drugs Dermatol, 23
A. Carruthers, S. Bruce, A. Coninck, S. Connolly, S. Cox, Paula Davis, A. Campo, X. Lei, Christine Somogyi, Elisabeth Lee, Helen Mclean, F. Beddingfield (2014)
Efficacy and Safety of OnabotulinumtoxinA for the Treatment of Crows Feet Lines: A Multicenter, Randomized, Controlled TrialDermatologic Surgery, 40
M de Maio (2004)
The minimal approach: an innovation in facial cosmetic proceduresDermatol Surg, 28
Carruthers (2014)
1181Dermatol Surg, 40
Beer (2011)
39J Drugs Dermatol, 10
Narurkar (2016)
S177Dermatol Surg, 42
Jones (2013)
1602Dermatol Surg, 39
A. Carruthers, J. Carruthers (2009)
A single-center dose-comparison study of botulinum neurotoxin type A in females with upper facial rhytids: assessing patients' perception of treatment outcomes.Journal of drugs in dermatology : JDD, 8 10
A. Carruthers, J. Carruthers (1998)
Clinical Indications and Injection Technique for the Cosmetic Use of Botulinum A ExotoxinDermatologic Surgery, 24
Sadick (2013)
266Aesthetic Plast Surg, 37
Baumann (2007)
S128Dermatol Surg, 33
A. Shamban (2015)
Customized Approach to Facial Enhancement.Facial plastic surgery clinics of North America, 23 4
S. Weinkle, W. Werschler, C. Teller, J. Sykes, A. Shamban, Alexander Rivkin, V. Narurkar, M. Kaminer, S. Dayan, Joel Cohen, Conor Gallagher (2018)
Impact of Comprehensive, Minimally Invasive, Multimodal Aesthetic Treatment on Satisfaction With Facial Appearance: The HARMONY StudyAesthetic Surgery Journal, 38
A. Carruthers, Kevin Kiene, J. Carruthers (1996)
Botulinum A exotoxin use in clinical dermatology.Journal of the American Academy of Dermatology, 34 5 Pt 1
S. Weinkle, D. Bank, Charles Boyd, Mitchell Gold, Jane Thomas, Diane Murphy (2009)
A multi‐center, double‐blind, randomized controlled study of the safety and effectiveness of Juvéderm® injectable gel with and without lidocaineJournal of Cosmetic Dermatology, 8
Carruthers (2016)
591Aesthet Surg J, 36
N. Sadick, Suveena Manhas-Bhutani, N. Krueger (2013)
A Novel Approach to Structural Facial Volume ReplacementAesthetic Plastic Surgery, 37
F. Brandt, B. Bassichis, M. Bassichis, Christopher O'connell, Xiaoming Lin (2011)
Safety and effectiveness of small and large gel-particle hyaluronic acid in the correction of perioral wrinkles.Journal of drugs in dermatology : JDD, 10 9
Carruthers (1998)
1189Dermatol Surg, 24
S Dayan, WP Coleman, JS Dover (2015)
Effects of onabotulinumtoxinA treatment for crow?s feet lines on patient-reported outcomesPlast Reconstr Surg, 41
J. Carruthers, A. Carruthers (2007)
Botulinum toxin type A treatment of multiple upper facial sites: patient-reported outcomes.Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.], 33 1 Spec No.
BackgroundOnabotulinumtoxinA and hyaluronic acid are effective in improving moderate to severe facial wrinkles and folds, with treatment selection traditionally based upon facial area.ObjectivesThis prospective, multicenter, open-label, crossover study evaluated physician-rated efficacy and patient-rated outcomes following moderate to severe facial wrinkles and folds treatment with onabotulinumtoxinA and hyaluronic acid.Methods152 subjects (25-65 years) were randomized (1:1) to a treatment-sequence of onabotulinumtoxinA/hyaluronic acid or hyaluronic acid/onabotulinumtoxinA, with initial treatment administered on day 1 and 6 additional visits: week 2 (touch-up); week 4 (crossover); week 6 (touch-up); and weeks 8, 12, and 24 (follow-up).ResultsBetween 92% and 100% of subjects in each treatment-sequence group exhibited at least some improvement from baseline at each study visit in the Physician Aesthetic Improvement Scale and the Objective Observer and Patient Global Assessments of Improvement, with no significant between-sequence differences. Subjects reported looking 3 to 6 years younger at each visit, with significant improvements in glabellar, lateral canthal, and horizontal forehead lines, and nasolabial folds. Treatments were well tolerated.ConclusionsOnabotulinumtoxinA and hyaluronic acid provide clinically meaningful improvements as rated by physicians, objective observers, and subjects, with clinical synergy in aesthetic effects and duration of response regardless of treatment administration order in subjects seeking improvement in moderate to severe facial wrinkles and folds.Level of Evidence: 2
Aesthetic Surgery Journal – Oxford University Press
Published: Jan 17, 2019
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.